Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » lymphoma

lymphoma

Jan 21, 2015

Incidental NIPT Finding Leads Leuven Team to New Blood Test for Hodgkin Lymphoma

Premium

The assay could be useful for identifying patients unlikely to respond to therapy and provide an alternative for monitoring therapy response.

Jan 06, 2015

Aegis Sciences Acquires MDx Firm Diagnovus

Diagnovus has developed a suite of oncology and gastroenterology tests using PCR, next-generation sequencing, and gene expression analysis.

Jan 05, 2015

Cancer Genetics Laboratory Receives California Approval to Offer Testing

The decision opens up the largest market in the country to the firm's lymphoma and leukemia testing services.

Dec 31, 2014

HTG Molecular Diagnostics Files for IPO of up to $60M

HTG plans to list its shares on the Nasdaq and is the 11th firm this year in the MDx/omics tools space to either go public or file for an IPO.

Dec 09, 2014

Immunosequencing Comes of Age as Researchers Demo Clinical Utility, Aim for FDA-cleared Products

Premium

Researchers are demonstrating that sequencing the immune repertoire can offer valuable insight into blood cancers, treatment response, and the likelihood of relapse.

Nov 20, 2014

Mirna Releases Phase I Data Showing Manageable Safety Profile for microRNA Rx

Premium

The data also indicate early signs of clinical activity in certain patients.

Nov 17, 2014

Sequenta, Illumina Strike IVD Deal for NGS-based Test to Monitor Residual Disease

Sequenta and Illumina have struck an agreement to commercialize an in vitro diagnostic kit based on Sequenta's minimal residual disease detection and quantification technology.

Sep 24, 2014

Denovo Taking on Failed Phase III Lilly Drug to Pursue for Genomic Responder Subset

Premium

NEW YORK (GenomeWeb) — Biomarker development firm Denovo Biopharma has acquired the late-stage oncology drug enzastaurin from Eli Lilly and Company, and plans to use its genotyping platform to uncover a genomic marker or markers that can support new clinical trials advancing the drug for a genomi

Sep 12, 2014

Advanced Cell Diagnostics Preps HPV Assay for Launch, Seeks Entry into Clinical Dx Market

NEW YORK (GenomeWeb) – After gaining traction in the research market, Advanced Cell Diagnostics is poised to bring its RNA detection technology to the clinical space.

Sep 03, 2014

Mirati Therapeutics Using NGS to Identify Best Responders to Multiple Oncology Drugs

Premium

NEW YORK (GenomeWeb) – Mirati Therapeutics is studying a number of personalized medicine cancer drugs, for which it is planning to use next-generation sequencing platforms to interrogate complex genetic markers associated with patient response.

Pages

The Scan

Hurdles to Genomic Surveillance

Nature News writes that viral genomic surveillance in the US faces systemic issues.

Boosts Requested

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

Early Trial Responses

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

PLOS Papers on Chronic Pain, Indigenous Populations in Mexico, SARS-CoV-2 Mutations

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.